Centene Corporation

Centene Corporation

CNC·NYSE

$59.55

-0.72%
HealthcareMedical - Healthcare Plans

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

At a Glance

Live Snapshot
Market Cap$29.41B
EPS-13.6100
P/E Ratio-4.38
Earnings Date07/28/2026
-13.41%
Return on Invested Capital
-364%
3Y-908.0%
5Y-419.0%
10Y-354.0%
-33.44%
Return on Equity
-367%
3Y-769.0%
5Y-577.0%
10Y-451.0%
-8.59%
Return on Assets
-314%
3Y-649.0%
5Y-427.0%
10Y-409.0%
Centene Corporation

Centene Corporation Management Team

CNC · NYSE
MK

Mr. Kenneth John Fasola

Advisor

Compensation

$2,793,778

Born 1960(Age 66)
male
MS

Ms. Sarah M. London

Chief Executive Officer & Director

Compensation

$5,972,016

Born 1981(Age 45)
female
MA

Mr. Andrew Lynn Asher

Chief Financial Officer

Compensation

$4,003,059

Born 1969(Age 57)
male
MB

Mr. Brian Phillip LeClaire M.B.A., Ph.D.

Chief Information Officer

Born 1960(Age 66)
male
MS

Ms. Susan R. Smith

Chief Operating Officer

Compensation

$1,868,145

Born 1976(Age 50)
female
MA

Ms. Ashlee Knuckey

Chief Risk, Ethics & Compliance Officer

female
MC

Ms. Cary D. Hobbs

Executive Vice President & Chief of Staff

Born 1968(Age 58)
female
MC

Mr. Christopher Andrew Koster

Executive Vice President, General Counsel & Secretary

Compensation

$2,142,654

Born 1965(Age 61)
male
MT

Ms. Tanya M. McNally

Senior Vice President & Chief People Officer

Born 1974(Age 52)
female
MK

Ms. Katie Nicole Casso

Senior Vice President of Finance, Corporate Controller and Chief Accounting Officer

Born 1982(Age 44)
female
MJ

Ms. Jennifer Lynch Gilligan

Senior Vice President of Investor Relations

female
cnc

Centene Corporation Insider Positioning

CNC · NYSE

During the last 12 months, insiders have purchased $739K and sold $2.58M worth of CNC shares, resulting in $1.84M of net selling activity.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

66.0K

2.58M

Net Activity

-2.6M

-$2.58M

9-12 Months

Bought

28.2K

738.95K

Sold

0

0.00

Net Activity

+739K

+$739K

Top Buyers

1
LS

London Sarah

Director, Officer: Chief Executive Officer

19.2K shares1 transactions

$490K

2
STRI

Samuels Theodore R. Ii

Director

9.0K shares1 transactions

$249K

Top Sellers

1
BKA

Burdick Kenneth A

Director

66.0K shares2 transactions

$2.58M

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $1.84M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.29:1

Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.

Insider Participation

Moderate Buying

2 insider buyers vs. 1 sellers. More insiders buying than selling indicates positive sentiment.

SEC Filings

CNC - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

March 26, 2026
May 12, 2026
2026
DEF 14A

DEF 14A 2025

N/A

March 27, 2025
May 13, 2025
2025
DEF 14A

DEF 14A 2024

N/A

March 28, 2024
May 14, 2024
2024
DEF 14A

DEF 14A

N/A

March 24, 2023
March 24, 2023
 
DEF 14A

DEF 14A 2022

N/A

August 11, 2022
September 27, 2022
2022
DEF 14A

DEF 14A 2022

N/A

March 11, 2022
April 26, 2022
2022
DEF 14A

DEF 14A 2021

N/A

March 12, 2021
April 27, 2021
2021
DEF 14A

DEF 14A 2020

N/A

March 13, 2020
April 28, 2020
2020
DEF 14A

DEF 14A 2019

N/A

March 08, 2019
April 23, 2019
2019
DEF 14A

DEF 14A 2019

N/A

December 26, 2018
January 28, 2019
2019
Showing 1 to 10 of 28 filings